Latinos are 1.5 times more likely to develop Alzheimer’s than their white peers. Its why diversity in clinical trials is absolutely critical. Fortunately, those studies can help us fight back against Alzheimer’s. If you are age 55 to 80, you can volunteer for the AHEAD Clinical Trial that aims to protect against the onset of Alzheimer's disease, led by the experts at the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio. “I got involved with the AHEAD clinical trial because both of my parents had Alzheimer’s,” Dave Ralberer, an AHEAD study participant and study partner, said. “My mother was 72 when she passed away. My dad has been struggling with the disease for 13 years. I have the unusual opportunity to be working with ...
Why did Emelina Asto-Flores volunteer for a clinical trial to test a COVID-19 vaccine? Asto-Flores, a community health educator in Florida, saw how the pandemic devastated Latinos, and she decided to enroll in the trial to help her people. Not only did she help researchers make sure the vaccine is safe for Latinos, but the trial also gave her the knowledge and confidence to encourage others to get their shot. “Representation is important in a clinical trial,” Asto-Flores said. “You wouldn't want a clinical trial to be just consisted of one group. These results need to be proportionate to our diverse communities. It's so important for us as members of the [Latino] community to take that leadership role that could save lives. So those that are a part of that can say, ...
Alzheimer’s disease hurts the quality of life of many of our beloved abuelos and abuelas, their family members, and caregivers. Fortunately, clinical trials can help us fight back against Alzheimer’s. You or your loved ones can volunteer for the REACH Clinical Trial that aims to slow the effects of Alzheimer’s disease, led by the experts at the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio. REACH Clinical Trial volunteers will be reimbursed up to $100 for each trial visit. “Our mission is to provide a compassionate and comprehensive network of clinical care for patients and their families with access to the most advanced treatment in clinical trials, as we continue to lead the search for a cure for Alzheimer’s and ...
In clinical trials, researchers test life-saving treatments and find ways to prevent and manage disease. But Latinos don't often participate in research. They account for less than 10% of people in federal cancer clinical trials. This makes it hard for researchers to create treatments that work best for Latinos. This is the focus of a new webinar, “Addressing Clinical Trial Enrollment Barriers in Unique Populations,” set for 1 p.m. ET Wednesday, April 21, 2021. The event is sponsored by Fight Colorectal Cancer. Register for the webinar. Panelists are: Amelie G. Ramirez, DrPh, is Director of the Salud America! program and its new project to engage more Latinos in cancer and Alzheimer's research (supported by a grant from Genentech, a member of the Roche Group), ...
Do you know fewer than 5% of Latinos participate in federal clinical trials? There is a historical lack of targeted research about Latino health inequities and how to address them, and a lack of diversity in clinical trials. Researchers thus have less chance to develop new treatments for this population, which suffers a heavy burden of certain cancers, dementia, obesity, and mental health issues. That's why we're excited to use #SaludTues on April 6, 2021, to tweet about how to increase Latino participation in clinical trials to prevent health disparities, to mark National Minority Health Month in April. WHAT: Tweetchat: “Latino Participation Is Vital in Clinical Trials"
TIME/DATE: 1-2 p.m. ET (Noon-1 p.m. CT), Tuesday, April 6, 2021
WHERE: On Twitter with hashtag ...
Historically and presently, Latinos are underrepresented in clinical research. Researchers want to increase diverse participation in clinical trials to ensure that Latinos and other underrepresented populations benefit from advances in public health and medicine, including personalized medicine. This is especially important amid a harmful pandemic that is disproportionately impacting Latinos. In hopes of increasing awareness among Latinos and people burdened by COVID-19, the National Health Institute's (NIH) Community Engagement Alliance (CEAL) Against COVID-19 Disparities Program created a new series of bilingual videos on clinical trials about vaccines and clinical trials to prevent and treat COVID-19. "[Our] program focuses on addressing misinformation around COVID-19, ...
There is a common health condition with serious medical consequences that has not been nationally recognized by the medical or public health community—toxic stress response. Toxic stress is the body’s response to prolonged trauma─like abuse or discrimination─with no support. It can harm lifelong mental, physical, and behavioral health, especially for Latinos and others of color. But few, if any, clinical treatment guidelines have strategies for mitigating the toxic stress response. That’s why Dr. Nadine Burke Harris’ Roadmap for Resilience: The California Surgeon General’s Report on Adverse Childhood Experiences, Toxic Stress, and Health wants California and others to recognize and respond to toxic stress as a health condition with clinical implications. “We ...
Across the board, Latinos are underrepresented in clinical research. Without adequate Latino and minority representation in clinical trials, researchers cannot find differential effects among groups nor advance public health and medicine. To address this, researchers across the country, like those at the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio, are creating educational interventions to recruit certain racial/ethnic groups in diseases like Alzheimer's that are on the rise among minorities. "Studies should represent the demographics of the country," Dr. Jonca Bull, an assistant commissioner on minority health at the Food and Drug Administration, said in a recent statement. "We need to close that gap so we can better ...
Latinos face an uphill battle when it comes to their health. They suffer many inequities, which are worsened amid the COVID-19 pandemic. Beyond that, there is a historical lack of targeted research about these inequities and how to address them, and a lack of diversity in clinical trials. This is the focus of a new webinar, "Conversations on Cancer: Latino Community—Achieving Equity in Cancer Clinical Trials," set for 1 p.m. ET Thursday, Sept. 24, 2020. The event is sponsored by the FDA's Oncology Center of Excellence. Register for the webinar. Panelists are: Amelie G. Ramirez, DrPh, Director of Salud America!, Professor and Chair of the Department of Population Health Sciences, and Director of the Institute for Health Promotion Research, all at UT Health San Antonio
...
